The FDA has granted full approval to verdinexor tablets (Laverdia; Anivive Lifesciences) for the treatment of dogs with lymphoma. The approval gives veterinarians a promising new oral avenue for ...

The discovery and introduction of corticosteroid therapy by Philip Hench in the late 1940s and early 1950s was a seminal advance in the treatment of inflammatory diseases, including rheumatoid ...

You can reduce osteoporosis risk with RA and care for bone health through effective treatments, lifestyle changes, and proper ...

Background A 55-year-old woman with vitiligo, hypothyroidism, interstitial lung disease and diabetes mellitus developed severe insulin resistance during a hospital admission for respiratory failure.

IgA nephropathy is a type of kidney disease that is typically treated with various medicines and lifestyle changes. Learn more about IgA nephropathy treatment here.

During a live event, Omid Hamid, MD, discussed the logistics and multidisciplinary process of using tumor-infiltrating ...

Americans can now purchase the starter dose of blockbuster weight-loss drug Wegovy as a pill, drug maker Novo Nordisk announced Monday. Other strengths will be available as pills by the end of the ...

Mounjaro’s typical starting dosage is 2.5 milligrams (mg) once per week for 4 weeks, after which your doctor may increase the dose to 5 mg per week if needed to manage blood sugar levels. The ...

The Central Drugs Standard Control Organisation (CDSCO) has granted multiple CT-18 approvals between January 2020 and ...

Despite his doctors’ recommendations, President Trump takes a high dose. By Nina Agrawal President Trump takes a high daily dose of aspirin, and has done so for over two decades, rejecting medical ...

Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, Dec. 31, 2025 /PRNewswire/ -- USA News Group News Commentary – Recent clinical trials achieving 83% insulin independence rates have ignited a ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...